Collectively, our results suggest that OLR1 expression levels are significantly elevated in the progression of various cancers and have the potential to serve as a prospective pan-cancer prognostic biomarker, particularly for COAD, HNSCC, LGG, and CHOL. The gene discussed is OLR1; the disease is cancer.